Education:iums.ac.ir/uploads/cvdrnaserypor.docx · Web viewCurriculum Vitae PERSONAL INFORMATION:...

Curriculum Vitae----------------------------------

PERSONAL INFORMATION:

Surname: NaseripourFirst name: MasoodTitle: MDWORK ADDRESS: Rassoul Akram Hospital, Niayesh Street, Sattar-khan Street. Tehran, Iran Phone: +982166509162 Academic degree: ProfessorThe University / Department: Ophthalmology Department / Iran University of Medical Sciences / Tehran / IranPhone number: +98-21-66509162 Fax: + 98-21-66509162E-mail: [email protected]

1

mailto:[email protected]

Education:

1983–1989 School of Medicine/ Tabriz University of Medical Sciences, Doctor of Medicine Tabriz, Iran 1989–1992 School of Medicine/ Tabriz University of Medical Sciences,

Ophthalmology, Tabriz, Iran 1993–1995 School of Medicine/ Iran University of Medical Sciences, Vitreoretinal surgery, Tehran, Iran 2000–2001 Wills Eye Hospital, ocular oncology, Philadelphia, USA

Work Experience:

Ophthalmologist / Member of Faculty/ Ophthalmology Department / Kermanshah University of Medical Sciences / 1995 – 2000

Head of Ophthalmology Department / Kermanshah University of Medical Sciences / 1996 – 1997

Deputy for Education and Research/ Kermanshah University of Medical Sciences / 1997 – 2000

Secretary of Iranian Council for Graduate Medical Education 2001-2004

Ophthalmologist / Member of Faculty /Ophthalmology Department / Iran University of Medical Sciences / 2001 – up to now

Head of Ophthalmology Department / Iran University of Medical Sciences / 2005 – 2007

Member of Board of Trustee/ Kermanshah University of Medical Sciences / 2004 – 2008

Head of IUMS Eye Research Center 2003-2010

2

SCIENTIFIC POSITIONS

1. Professor, Director of Ocular Oncology unit, Eye Department, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

2. Scientific Member, Iranian Retina Society, Tehran, Iran, since 2001.

3. Scientific Reviewer for the journal of “ BINA”, Iranian Eye Bank journal, Iran, since 2002.

4. Scientific Reviewer for the journal of “ Ir J Ophthalmology”, journal of the Iranian Society Of Ophthalmology, Iran, since 2002.

5. Scientific Reviewer for the journal of “ Behbood”, Kermanshah University of medical sciences , since 1998.

6. Editorial Board for the journal of “ Ir J Ophthalmology”, journal of the Iranian Society Of Ophthalmology, Iran, since 2005.

7. Editorial Board for the journal of “ Behbood”, Kermanshah University of medical sciences , since 1998.

8. Editorial Board for the journal of “ Medical Education”, Shahid Beheshti University of medical sciences , since 2003

9. Scientific Reviewer for the journal of “ Saudi Journal of Ophthalmology”, Saudi Arabia since 2010

10. Scientific Reviewer for the journal of “Middle East African Journal of Ophthalmology”, Middle East African Council of Ophthalmology2012

3

Publications:

1) Naseripour M, Parvaresh MM. Predisposing factors of Retinal Detachment and Prophylactic

Treatment. Iranian Ophthalmology journal of bina 1996; 1( 4): 47-64

2) Naseripour M, Parvaresh MM. Prophylactic Laser Treatment in Patients with Symptomatic

Retinal Breaks. Bina J Ophthalmol 1999; 4(2):128-133

3) Naseripour M, Parvaresh MM. Scleral buckling Result and Related Risk factors. Iranian

Ophthalmology journal of bina 1999; vol 4(4): 335-340

4) Naseripour M, Iranfar S. Evaluation of Educational Activities of the Faculty of Kermanshah

University of Medical Sciences from medical student’s Standpoint. Iranian journal of Behbood

2000; vol 4( 3): 27-32

5) Naseripour M, Shields CL, Shields J, Guyer DR. Pseudohypopyon of Orange Pigment

Overlying a Stable Choroidal Nevus. Am j Ophthalmol 2001; 132: 416-417.

6) Shields CL, Naseripour M, Shields J. Topical Mitomycin C for Extensive Recurrent

Conjunctival-Corneal Squamous Cell Carcinoma. Am j Ophthalmol 2002; 133: 601-606.

7) Mirzazadeh A, Tavakoli S, Naseripoor M. Comparison of Graduate Medical Education in Iran

with WFME International Guidelines: Quality Improvement in Postgraduate Medical Education.

Iranian Journal of Medical Education. No. 8, 2002. 37-38.

8) Shields J, Shields CL, Naseripour M, Eagle RC, Miller J. Choroidal Melanoma in a Black

Patient with Oculodermal Melanocytosis. Retina 2002; 22: 126-128

4

9) Shields CL, Naseripour M, Shields J, Eagle RC. Topical Mitomycin C for Pagetoid Invasion

of the Conjunctiva by Eyelid Sebaceous Gland Carcinoma. Ophthalmology 2002; 109: 2129-

2133.

10) Shields CL, Naseripour M, Cater J, Shields J, Demirci H, Youseff A, Freire J. Plaque

Radiotherapy for Large Posterior Uveal Melanomas in 354 Consecutive Patients.

Ophthalmology 2002; 109: 1838-1849.

11) Shields CL, Naseripour M, Shields J, Freire J, Cater J. Custom-Designed Plaque

Radiotherapy for Nonresectable Iris Melanoma in 38 Patients: Tumor Control and Ocular

Complications. Am J Ophtalmol 2003; 135: 648- 656.

12) Panda, A., Bajaj, M.S., Balasubramanya, R., Prakash, G., Shields, C.L., Naseripour, M., Shields,

J.A.

Topical mitomycin C for conjunctival-corneal squamous cell carcinoma [1] (multiple letters)

(2003) American Journal of Ophthalmology, 135 (1), pp. 122-124.

13) Naseripour M, Parvaresh MM, Bakhtiari P, Afsar N. Transpupillary Thermotherapy for

Treatment of Occult Subfoveal Choroidal Neovascularization in Age Related Macular

Degeneration. Iranian J Ophthalmol 2004; 17(3):49-57.

14) Mirzadeh A, Hashemi H, Naseripour M, Fotouhi A, Yazdani K, Tavakoli S, Raisi B, Taj M.

Establishment of New Evaluation and Accrediation System for Graduate Medical Education in

Iran. Journal of Medical Education summer 2004; 5(2):69-73.

15) Naseripour M, Bakhtiari P, Mogadam AZ, Vosogh P, Naseripour Majid, Salimi S. Combined

chemoreduction and adjuvant therapy to control advanced retinoblastoma. Iranian Journal of

Ophthalmology 2005; 18(4.): 91-98.

5

16) Naseripour M. Retinoblastoma. Iranian Journal of Ophthalmology 2006; 19(1.): 35-48.

17) Naseripour M, Ansari MR, Sheikhi F, Danesghgar F, Omidian J, Ghaderi E. Retinopathy

Prevalence and Its Risk Factors in Diabetics at Kermanshah Diabetes Research Center (1994-

2000). Iranian journal of Behbood 2006; 9(4): 44-51.

18) Naseripour M, Bakhtiari P, Salimi S, Kashkouli MB, Sadeghipour AR. Rubeosis iridis

complicating acquired astrocytoma of solitary optic nerve head; A clinicopathologic case

report. Iranian Journal of Ophthalmology 2006;19:60-64.

19) Sanjari S, Falavarjani GK, Parvaresh MM, Modarres-zadeh M, Naseripour M, Nojomi

M. Vitreopapillary Traction in Non-arteritic Anterior Ischemic Optic Neuropathy. Bina J

Ophthalmol, 2006; 11(3):289-293.

20) Sanjari MS, Falavarjani KG, Parvaresh MM, Modarreszadeh M, Naseripour M, Nojomi

M. Vitreopapillary Traction in Nonarteric Anterior Ischemic Optic Neuropathy. Iranian J

Ophthalmic Res 2006; 1(2): 110-112.

21) Naseripour M, falavarjani KG, Akbarzadeh S. Retinocytoma Associated with Bilateral

Retinoblastoma. Bina J Ophthalmol 2007;1 (13):130-132.

22) Kashkouli MB, Salimi S, Aghaee H, Naseripour M. Bilateral pseudomonas aeruginosa

endophthalmitis following bilateral simultaneous cataract surgery. Indian J Ophthalmol.

2007 sep- oct; 55 (5):374-375.

23) Kashkouli MB, Reaee R, Nilforoushan N, Salimi Sh, Foroutan AR, Naseripour M. Topical

Antiglaucoma Medications and Lacrimal Drainage system obstruction. Ophthal Plast Reconstr

surg 2008; 24 (3):172-5.

6

24) Sadeghipour AR, Abolhasani M, Naseripour M. Association of Vessel Density and Vascular

Endothelial Growth Factor with Local Invasive Growth in Ocular Retinoblastoma,Hazrat

Rasool Akram Hospital 2000-2006. Journal of Iran University of Medical Sciences. 2008; 57

(14): 133-141.

25) Naseripour M, Akbarzadeh S, Ahadian A, Vosough P. The Role of periocular

carboplatin in treatment of advanced intraocular retinoblastoma. Iran J Ophthalmol 2008;

20(1):16-19.

26) Kashkouli MB, Salimi S, Bakhtiari P, Parvaresh MP, Sanjari MS, Naseripour M. EMLA

Cream Application without Occlusive Dressing Before upper facial Botulinum Toxin

Injection. A Randomized Double-Blind Placebo-Controlled Trial. Annals of plastic Surgery

Volume 60, Number 4, April 2008; 353-356.

27) Naseripour M, Nazari H, Bakhtiari P, Modarreszadeh M, Vosough P, Ansari M.R, Ahadian A.

Investigation of Outcomes and Prognosis of Patients with Retinoblastoma after Primary

Chemotherapy and Focal Treatment Based on International (A-E) Classification. Bina J

Ophthalmol 2008; 14(1): 3-9.

28) Moderreszadeh M, Naseripour M, Falavarjani KG, Nikeghbali A, Hashemi M, Paravaresh

MM. Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal

Neovascularization Associated with Age Related Macular Degeneration . J Ophthalmic Vis Res

2008; 3(2): 102-107.

29) Naseripour M, Nikeghbali A, Vadipour A, Bakhtiari P, Ahadian A. Combined Tranpupillary

thermotherapy with subtenon triamcinolone injection in treatment of choroidal

neovasculariaztion secondary to exudative age related macular degeneration. Armaghane danesh

J 2008; 13 (1): 1-13.

7

30) Naseripour M, Kashkouli MB, Jaberi MS, Aghaee GH, Ahadian A. Plaque Radiotherapy in

Recurrent or Incomplete-Excised Conjunctival Squamous Cell Carcinoma and Melanoma.

Iranian J Ophthalmol 2008; 20 (3): 19-23.

31) Naseripour M, Nazari H, Bakhtiari P, Modareszadeh M, Vosough P, Ansari MR, Ahadian A.

Outcomes and prognosis of treatment for retinoblastoma with primary chemotherapy and focal

treatment. Bina J ophthalmology 2008, 14 (1):3-9.

32) Naseripour M, Nazari H, Bakhtiari P, Modarres M, Vosough P, Ausari M. Retinoblastoma in

Iran: outcomes in terms of patients' survival and globe survival. (2009) Br J ophthalmol. Jan; 93

(1):28-32.

33) Naseripour M, Akbarzadeh S, Bakhtiari P, Ahadian A. Adjuvant Effects of Periocular

Chemotherapy in Treatment of Advanced Intraocular Retinoblastoma. Journal of Iran

University of Medical Sciences 2008 . 62(16)187-193

34) Modares-zadeh M. Naseripour M, Falavarjani KG, Nikeghbali A, Hashemi M, Parvaresh

MM. Intravitreal Injection of 2.5 mg VERSUS 1.25 mg Bevacizumab (Avastin) for

Treatment of Choroidal Neovascularization(CNV) Associated with Age-related Macular

Degeneration (AMD). Retina 2009 mar; 29(3): 319-24.

35) Naseripour M, Falavarjani KG, Mirfallah K, Begheri SR. Photodynamic therapy for

vasoproliferative tumors and capillary hemangiomas of retina. Bina J Ophthalmol 2009;

14(2): 109-115.

،هانیه محمد رضا، صدیقه مرجان�ه حج�ازی، محم��د علی عقابی�ان، علیرض��ا احم��دیان (36 ، محمد رضا زرین، خلی��ل قاس��می فالورج��انی، حس��ین نظ��ری.مسعود ناصری پور

اندازه گیری مساحت عروق تازه تشکیل شده ناش��ی از بیم��اری اس��تحاله وابس��ته ب��ه

8

سن ماکوال با استفاده از روش آستانه گذاری اتسو تغییر یافته. مجله فیزی��ک پزش��کی. 87(، پاییز و زمستان 20،21، پیاپی )2 شماره 5ایران، دوره

37) Nazari H, Modarreszadeh M, Kashkouli MB, Naseripour M, Parvaresh MM, Nazari P. Central

retinal artery perfusion following 0.1 ml intravitreal injection of Bevacizumab. Iran J

Ophthalmol 2009;21(2):13-18.

38) Naseripour M, Nazari H, Bakhtiari P, Ahadian A, Jaberi R. Ruthenium 106 Plaque for retinal

vasoproliferative tumors. Iran J Ophthalmol 2009;21(2):31-35.

39) Saadat S, Naseripour M, Rahimi B. Safety preparedness of urban community for new year

fireworks in tehran. In press BURNS. Burns 35(2009) 719-722.

40) Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM.

Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic

retinopathy. Eur J Ophthalmol 2009; 19: 848-852.

41( Naseripour M, Falavarjani GH, Oladi MR, Modarre M. Testing Toxicity of Intravitreal

Bevacizumab (Avastin) used for the Treatment of Choroidal Neovascularization

Associated with Age-Related Macular Degeneration: A Full Field ERG Study. Iranian

Journal of Ophthalmology 2009;21(3):49-55

42) Falavarjani KG, Nikeghbali A, Modarreszadeh M, Hashemi M, Parvaresh MM,

Naseripour M. Longterm Results of Fixation of Dislocated Intra Ocular Lenses Using

Hoptic Externalization Through a Clear Corneal Incision. No 63 vol 16 Journal of Iran

University of Medical Sciences 2009.

9

43) Naseripour M, Falavarjani KG, Bakhtiari P, Vosough P, Aryad F. Retinoblastoma

survival in iran 10 tears experience of a referral center. Iranian Journal of Ophthalmology

2009;21(4):17-24.

2010

44) Saadat S, Naseripour M, Smith GA. The health and economic impact of fireworks-related

injuries in Iran: a household survey following the New Year's Festival in Tehran. Injury. 2010

Jul;41(7):e28-33.

45) Naseripour M, Falavarjani KG, Akbarzadeh S. Retinocytoma associated with bilateral

retinoblastoma. Indian J Ophthalmol. 2010 Mar-Apr;58(2):155-156.

46) Saadat S, Naseripour M, Karbakhsh M, Rahimi Movaghar V. Perceived risk and risk-

taking behavior during the festival firework. Am J Health Behav. 2010;34(5): 525-531.

47) Falavarjani KG, Modarres M, Nazari H, Naseripour M, Parvaresh MM. Diabetic macular

edema following panretinal photocoagulation. Arch Ophthalmol. 2010 Feb;128(2):262;

48) Falavarjani KG, Mohammadreza H, Marjaneh Hejazi S, Naseripour M. A Modified

Semiautomatic Method for Measurement of Hyperfluorescence Area in Fluorescein

Angiography. Iranian Journal of Ophthalmology 2010;22(4):73-79 .

49) Saadat S, Naseripour M, Karbakhsh M, Rahimi-Movaghar V. Perceived risk and risk-

taking behavior during the festival firework. Am J Health Behav. 2010 Sep-Oct;34(5):525-

531.

50) Falavarjani KG, Naseripour M. New hope for retinoblastoma patients. J Ophthalmic Vis Res.

2010 Jul;5(3):213-4.

10

http://www.ncbi.nlm.nih.gov/pubmed/22737361







51) Falavarjani KG, Modarres M, Nazari H, Naseripour M, Parvaresh MM. Diabetic macular

edema following panretinal photocoagulation. Arch Ophthalmol. 2010 Feb;128(2):262;

52) Samiy N, Harandi ZA, Naseripour M, Lai TY. Bilateral elevated macular lesions. J

Ophthalmic Vis Res. 2011 Jan;6(1):55-62.

53) Naseripour M, Retinoblastoma survival disparity’’: The expanding horizon in developing

countries. Saudi J of ophthalmology (2012) 26, 157-161.

54) Kashkouli MB, Heirati A, Pakdel F, Kiavash V, Naseripour M, Aghamohammadi F. Long-

term follow-up of invasive ocular surface squamous cell carcinoma treated with excision,

cryotherapy, and topical mitomycin C. (2012) Graefe's Archive for Clinical and Experimental

Ophthalmology, 250 (10), pp. 1527-1532.

55) Naseripour M. Retinoblastoma survival disparity’’: The expanding horizon in developing

countries. Saudi J of ophthalmology (2012) 26, 157-161.

56) Falavarjani KG, Modarres M, Hashemi M, Parvaresh MM, Naseripour M, Zare-Moghaddam

A, Nekoozadeh S. Incidence of Acute Endophthalmitis after Intraviteral Bevacizumab

Injection In a single clinical center. Retina. 2013 Feb 7. [Epub ahead of print]

57) Saliminejad, K., Behnam, B., Akbari, M.T., Khorshid, H.R.K., Ghassemi, F., Amoli, F.A.,

Akhondi, M.M., Vosoogh, P., Naseripour, M., Ahani, A. Rapid detection of RB1 recurrent

mutations in retinoblastoma by ARMS-PCR. (2013) Journal of Genetics, pp. 1-5. Article in

Press.

58) Falavarjani, K.G., Modarres, M., Hashemi, M., Parvaresh, M.M., Naseripour, M., Zare-

Moghaddam, A., Nekoozadeh, S. Incidence of acute endophthalmitis after intravitreal

bevacizumab injection in a single clinical center. (2013) Retina, 33 (5), pp. 971-974.

11


http://www.ncbi.nlm.nih.gov/pubmed?term=Nekoozadeh%20S%5BAuthor%5D&cauthor=true&cauthor_uid=23400076

http://www.ncbi.nlm.nih.gov/pubmed?term=Zare-Moghaddam%20A%5BAuthor%5D&cauthor=true&cauthor_uid=23400076

http://www.ncbi.nlm.nih.gov/pubmed?term=Zare-Moghaddam%20A%5BAuthor%5D&cauthor=true&cauthor_uid=23400076

http://www.ncbi.nlm.nih.gov/pubmed?term=Naseripour%20M%5BAuthor%5D&cauthor=true&cauthor_uid=23400076

http://www.ncbi.nlm.nih.gov/pubmed?term=Parvaresh%20MM%5BAuthor%5D&cauthor=true&cauthor_uid=23400076

http://www.ncbi.nlm.nih.gov/pubmed?term=Hashemi%20M%5BAuthor%5D&cauthor=true&cauthor_uid=23400076

http://www.ncbi.nlm.nih.gov/pubmed?term=Modarres%20M%5BAuthor%5D&cauthor=true&cauthor_uid=23400076

http://www.ncbi.nlm.nih.gov/pubmed?term=Falavarjani%20KG%5BAuthor%5D&cauthor=true&cauthor_uid=23400076







59) Ahani, A., Akbari, M.T., Saliminejad, K., Behnam, B., Akhondi, M.M., Vosoogh, P.,

Ghassemi, F., Naseripour, M., Bahoush, G., Khorshid, H.R.K. Screening for large

rearrangements of the RB1 gene in Iranian patients with retinoblastoma using multiplex

ligation-dependent probe amplification. (2013) Molecular Vision, 19, pp. 454-462.

60) Khalil Ghasemi Falavarjani, Masih Hashemi, Mehdi Modarres, Mohammad Mehdi Parvaresh,

Masood Naseripour, Hossein Nazari, Ali Jalili Fazel. Vitrectomy for Posterior Segment

Intraocular Foreign Bodies, Visual and Anatomical Outcomes. Middle East African Journal of

Ophthalmology, Volume 20, Number 3, July - September 2013

12

RESEARCH PROJECTS:1. Congenital Cataract Incidence in Tabriz 1992

2 Diabetic Retinopathy Cumulative Incidence Rate and Related Risk factors in "Diabetic Research Center" patients. 1993

3. Efficacy of Argon laser Trabeculoplasty in Primary Open Angle Glaucoma. 1995

4. Epidemiological Study of Diabetic retinopathy and risk factors since Diagnosis in diabetic patients of Kermanshah Diabetic Research center. 1999

5. Health and Diseases Evaluation in Community Based Medical Education Field in Kermanshah 1999

6. Efficacy of Transpupillary Thermotherapy for Occult Sub-foveal CNV. 2003

7. Efficacy of Sub threshold Grid Laser photocoagulation in Patients with symptomatic 2003 8 The Determination of prevalence of eye related macular degeneration in population after than 40 years old in Kermanshah province in 2005

9. Macular thickness and retinal nerve fiber layer thickness evaluation following brachytherapy of intra-ocular tumors. 2004

10. Combined chemoneduction and periocular carboplatin in treatment of advanced retinoblastoma. 2004

11. The evaluation of the results of ruthenium 106 plaque radiotherapy for the treatment of intraocular choroidal malignant melanoma. 2005

12. Comparison of different dose (1.25 and 2.5mg) of intravitreal Bevacizumab (Avastin) with combined intravitreal Avastin (1.25 mg) and Triamcinolon (2 mg) in exudative age-related macular degeneration. A double-blind clinical trial. 2005

13. The investigation of outcomes and prognosis of patients with Retinoblastoma following primary chemoreduction and focal treatment based on International (A-E) classification 2006.

14. Electrophysiologic findings (GERG) after interavitreal Avastin (Bevacizumab) treatment in choroidal neovascular membrane. 2007

15. The evaluation of the Photodynamic therapy for retinal vascular tumors of retina. 2008

16. Designing and development of a calculating system to measure the hyperfleurecent areas in retinal angiography. 2008

17. Investigation of Sandwichtherapy for Choroidal Melanoma

13

18. Comparative study of disease–free ratio in the patients with uvula melanoma and monosomy-3 with and without adjuvant therapy (temozolamid and peginterferon α-2b). 2008

19. The evaluation of the results of primary transpupillary thermotherapy in posterior pole small choroidal melanomas. 2008

20. Detection of Mutations in total exon and promotor of the Rb1 gene in hazrate rasol hospital retinoblastoma patients by using exon by exon PCR-SSCP analysis. 2008

21. Incidence rate of injuries due to fire work at last Wednesday of solar year in Tehran. 2005

22. Mutation profiling of RB1 gene in patients with retinoblastoma . 2009

23. Photodynamic therapy for retinal vasoproliferative and angiomatous tumors of retina. 2008

24. Frequency of Monosomy-3 in patients with uveal melanoma according to Chromosome in

situ hybridization in patients attending to in Rasoul Akram Hospital from 2003 to 2013 . 2011

25. Preparation and In Vivo Evaluation of Nanoliposomes containing Melphalan after Intravitreal Administration . 2011

14

Conference Presentations:

1) Deep Vitrectomy Result in Patients with Active PDR.

4th National Ophthalmologic seminar, Tehran, Iran 1994

2) Episcleral Balloon in Patients with Retinal Detachment.

5th Ophthalmology Congress, Tehran, Dec. 1995

3) Retinal Detachment Management by Episcleral Parabulbar Balloon. The First Report from Iran

The First International Ophthalmology Congress, Tehran-Iran, 1995

4) Prognostic Factors in Intraocular Foreign Bodies.

7th Iranian Ophthalmologic Congress, Isfahan, Iran 1997

5) Results of Prophylactic Laser therapy in retinal detachment.

8th Ophthalmologic Congress, Tehran, Iran 1998

6) Scleral buckling Result and Prognostic Factors.

8th Ophthalmologic seminar, Tehran, Iran 1998

7) New in Retinoblastoma.

Second International Ophthalmology Congress, Tehran-Iran, 2001

8) Management of Choroidal Malignant Melanoma.

2nd International Ophthalmology Congress, Tehran, Iran, 2001

9) Health and Diseases Status in Aged People in Community Oriented Medical Education Field in

Kermanshah.

2nd Health and Preventive Medicine Seminar, Kermanshah, Iran, 2001.

15

10) Prevalence of Abnormal Red Reflex in Community Based Medical Education Field in

Kermanshah. Kermanshah, Dec. 2001

11) Retinoblastoma: Early Diagnosis or Presenting Symptoms Education?

23rd Congress of advances in Pediatric, Tehran, May 2002

12) Evaluation of Patients with Intraocular Tumor.

Tehran, Iran, Feb 2002.

13) Analytic Comparison of New Accreditation System for Graduate.

Medical Education in Iran with ACGME and RCPSC Ahwaz, 2002

14) How to Approach to a Patient with Intraocular Tumor.

Shahid Beheshti UMS. Tehran, Feb 2002.

15) Transpupillary Thermotherapy for Treatment of Occult Choroidal Neovascularization.

13th Ophthalmology Congress, Tehran, Dec. 2003.

16) Partial Lamellar Sclerouvectomy for Management of ciliary Body tumors.

13th Ophthalmology Congress, Tehran, Dec. 2003.

17) Transpupillary Thermotherapy for Management of Choroidal Melanoma.

13th Ophthalmology Congress, Tehran, Dec. 2003

18) Partial Lamellar Sclerouvectomy:A Safe Procedure for Saving the Eyes with Ciliary body

Tumor.

XI International Congress of Ocular Oncology Jan 2004, Hyderabad, India

16

19) Are Combined Chemoreduction and Adjuvant treatment Sufficient to Control the Patients with

Advanced Retinoblastoma?

XI International Congress of Ocular Oncology Jan 2004, Hyderabad, India

20) Visual Results Following Transpupillry Thermotherapy of Choroidal Neovascularization In

Patients with Exudative ARMD.

4th EURETINA Congress, Milan, Italy, May 2004.

21) Transpupillary Thermotherapy of Occult and Classic Choroidal Neovascularization in Patients

with Age-Related Macular Degeneration.

Naseripour M, Parvaresh M.M, Bakhtiari P, Afsar N, Dec 2004.

14th Iranian Congress of Ophthalmology 14-17 December 2004 Tehran

22) Ruthenium 106 Plaque Radiotherapy in Intraocular Tumors.

Naseripour M, Tarassoli K, Jaberi R, Samiee F, Dec 2004.


23) Combined Chemoreduction and Adjuvant Therapy to Control Retinoblastoma.

Naseripour M, Bakhtiari P, Zare Moghadam A, Vosough P. Dec 2004.


24) Optic Disc Astrocytoma Case Report.

Naseripour M, Bakhtiari P, Imani M, Dec 2004.


25) Medulloepithelioma of Ciliary Body.

Naseripour M, Bakhtiari P, ZareMoghadam A, Dec 2004


17

26) Surgical and Anatomic Outcome of Pars Plana Vitrectomy with Silicon Oil Tamponade without

Buckle Placement for the Treatment of Primary Rhegmatogenous Retinal Detachment

Parvaresh MM, Naseripour M, Bakhtiari P.

20th ASIA Pacific Academy of Ophthalmology Congress

27) Prevalence and Risk Factors of Supra-choroidal Hemorrhage in Scleral Surgery

Bakhtiari P, Parvaresh MM, Naseripour M.

20th ASIA Pacific Academy of Ophthalmology Congress

28) Ruthenim 106 plaque radiotherapy in treatment of choroidal tumor.

Naseripour M, Bakhtiari P, Jaberi R, Kheirkhah R, Samiee F.

International VIIIth Congress of the Pan Arab African Council of Ophthalmology (PAACO) and

the XIIth UAE Ophthalmic Conference April2005 Dubai

29) Combined Chemoreduction and Adjuvant Therapy to Control Retinoblastoma.

Naseripour M, Bakhtiari P, Moghadam A, Vosough P, Nasrabadi M

International VIIIth Congress of the Pan Arab African Council of Ophthalmology (PAACO) and

the XIIth UAE Ophthalmic Conference April 2005 Dubai (P)

30) Optic Nerve Astrocytoma

Naseripour M, Bakhtiari P, Imani M,Sadeghipour.

Ophthalmology (PAACO) and the XIIth UAE Ophthalmic Conference April 2005 Dubai (P)

31) Do We Need Effective Modalities to Control the Patients with Advanced Retinoblastoma?

Naseripour M, P. Bakhtiari, SH. Salimi, P Vosough.

ISGED and IRS 2005 & ICOO 2005 Canada

32) Regression of Advanced Retinoblastoma after Multiple Subconjunctival Carboplatin Injection

Naseripour M, N. Bahrivand, A. Vadipour, P. Bakhtiari

18


33) Plaque Radiotherapy in Vitrectomized Eye with Recurrent Retinoblastoma

Naseripour M, M Hashemi, R Jaberi, M Almasi Nasrabadi


34) Transpupillary Thermotherapy (TTT) for Treatment of Idiopathic Choroidal

Neovascularization(o)

Naseripour M, Nikeghbali A, Ariaeetabar H, Bakhtiari P.

15th Iranian Congress of Ophthalmology. 15-18 December 2005 Tehran

35) Brachytherapy Using Ruthenium-106 Plaque for Choroidal Management Methods (O)

Naseripour M, Jaberi R, Bakhtiari P, Kheirkhah A, AliAkbar Navahi R


36) Case-Control Study of Occurrence of Predictors of Anterior Hyaloid Fibro vascular Proliferation

after Diabetic Vitrectomy .

Parvaresh MM, Naseripour M, Bakhtiari P, Khodadoust A


37) Intravitreal Triamcinolone Injection for Treatment of Macular Edema Due to BRVO (O)

Hashemi M,Parvaresh MM, Naseripour M, Manshai K


38) Intravitreal Triamcinolone Injection for the Treatment of Macular Edema due to CRVO (O)

Hashemi M, Parvaresh MM, Naseripour M, Manshai K


39)Intravitreal Triamcinolone Injection for CSME as Primary Treatment (O)

19

Hashemi M, Parvaresh MM, Naseripour M, Manshai K


40) Transpupillary Thermotherapy (TTT) for Treatment of Choroidal Neovascularization due to

Myopia (P)

Naseripour M, Hashemi M, Ariaeetabar H, Bakhtiari P


41) Transpupillary Thermotherapy (TTT) for Treatment of

Occult, Classic and Mixed-Type Choroidal Neovascularization (CNV) in Age Related Macular

Degeneration (ARMD) (O)

Naseripour M, Parvaresh MM, Bakhtiari P, Manshai K,Salimi SH


42) Transpupillary Thermotherapy (TTT) as primary Treatment or Adjuvant to plaque Radiotherapy

for Choroidal Malignant Melanoma (O).

Naseripour M, Parvaresh MM, Ariaeetabar H, Bakhtiari P


43) Do We Need More Effective Modalities to Control the Patients with Advanced Retinoblastoma?

(O) . Naseripour M, Bakhtiari P, ZareMoghadam A, Salimi SH, Vosough P


44) Nerve Fiber Layer (NFL) and Macular Thickness Measurment by Optical Coherence

Tomography

(OCT) in Emmetropic, High Myopic and High Hyperopic Eyes

Parvaresh MM, Imani M, Naseripour M, Bakhtiari P, Salimi SH


20

45) Ten years Survival Rate Study of Patients with Retinoblastoma in Iran.

Naseripour M, P Vosough, F Arian, P Bakhtiari, SH Salimi

Saudi Ophthalmology Congress March 2006

47) Case- Control Study of Occurrence of Predictors of Anterior Hyaloid Fibrovascular

Proliferation Naseripour M, M Parvaresh, P Bakhtiari, A Khodadoust


48) Brachytherapy Using Ruthenium -106 Plaque for Choroidal Melanoma

Naseripour M, R Jaberi, P Bakhtiari, A Kheirkhah, S Ali


49. Optical Coherence Tomography (OCT) in Emmetropic, High-Myopic and High- Hyperopic

Eyes.

Naseripour M, M Parvaresh, P Bakhtiari, M Imani, A Kheirkhah


50. Plaque Brachytherapy in Uveal Melanoma

Ramin Jaberi, Naseripour M, Farhad Samiei

The 3 th National Scientific Congress of IRSA 2005

51. The role of hyperthermia in control of subfoveal CNV: stabilization of CNV with low recurrent

rate.

Naseripour M, Pejman Bakhtiari,

XVI Ophthalmology Congress of Iran , November 2006

52. Evaluation of periocular carboplatin injection combined with chemotherapy for advanced

intraocular retinoblastoma . Naseripour M, Akbarzadeh S, Bakhtiari P, Vosough P, Vadipour A

XVI Ophthalmology Congress of Iran, November 2006

21

53. Efficacy of the Intravitreal Injection of Bevacizumab (Avastin) For Treatment of Wet – Type

ARMD.

Naseripour M, Ansari MR, Modarreszadeh M, Bakhtiari P, Salimi Sh

XVI Ophthalmology Congress of Iran

November 2006

54. Plaque Radiotherapy for ocular surface tumors.

Naseripour M, Ansari MR, Jaberi R, Bakhtiari P, Salimi Sh.

XVI Ophthalmology Congress of Iran November 2006

55. Ten Years Survival Rate Study of Patients with Retinoblastoma In Iran.

Naseripour M, Vosough P, Arian F, Bakhtiari P, Salimi SH.

XVI Ophthalmology Congress of Iran , November 2006

56. The effect of transpupillary thermotherapy with or without Sub – Tenon triamcinolon injection

for the treatment of CNV due to ARMD.

Naseripour M, Vadipour A, Parvaresh MM, Bakhtiari P, Salimi Sh

XVI Ophthalmology Congress of Iran, November 2006

57. High dose versus low dose ruthenium 106 plaque radiotherapy for retinal vasoproliferative

tumors (VPT).

Naseripour M , Bakhtiari P, Jaberi R

ISOO MEETING 2007, International Society of Ocular Oncology, Siena, 26-30 June 2007

58. The prognosis of retinoblastoma in terms of patient’s survival and globe survival

Naseripour M., Bakhtiari P., Ansari M.R., Vosough P.


22

59. Retinoblastoma: Predictor factors for patients survival

Naseripour M., Bakhtiari P., Vosough P., Arian F.


60. Ruthenium 106 plaque radiotherapy for choroidal malignant melanoma: 5 years experience.

Naseripour M, Nazari H, Bakhtiari P, Jaberi R.


61. Visual and anatomical results of brachytherapy in circumscribed choroidal hemangioma.

Naseripour M, Bakhtiari P, Nazari H, Jaberi R


62) High Dose versus Low Dose Ruthenium 106 Plaque Radiotherapy for Retinal Vasoproliferative

Tumors.

Naseripour M, Bakhtiari P, Nazari H, Jaberi R

17th Iranian Congress of Ophthalmology, Tehran, 4-7 December 2007.

63) Intravitreal Injection of Bevasizumb before Vitrectomy for Proliferative Diabetic Retinopathy;

Modarreszadeh M, Naseripour M.

17th Iranian Congress of Ophthalmology . Tehran, 4-7 December 2007.

64) Ruthenium 106 Plaque Radiotherapy for Choroidal Malignant Melanoma: 5 Years

Experiences.; Naseripour M, Bakhtiari P, Jaberi R.

17th Iranian Congress of Ophthalmology. Tehran, 4-7 December 2007.

65) Intravitreal Injection of Bevacizumab for Treatment of Macular Edema after Retinal Vein

Occlusion.

Naseripour M, Modarreszadeh M, Ansari MR, Falavarjani KG.

Middle East African council of ophthalmology . UAE, Dubai. April-March 2007.

23

66) Ruthenium-106 Plaque Radiotherapy for Choroidal Malignant Melanoma: 5 Years Experinces;

Naseripour M, Nazari H, Bakhtiari P, Jaberi R.

4th Asian Congress of Safe Communities. Thiland, 21-24 November 2007.

67) Bevacizumab and Retinal Ischemia

Naseripour M, MD.

Annual meeting of Retina society. Iran, Zibakenar, 15 May 2008.

68) Age related macular degeneration

Naseripour M, MD.

11th Annual Optometry Congress, Sep 2007 Tehran, Iran.

68- Current and New pharmacologic treatments of ARMD

Retina and Vitreous Seminar, June 2006 Tehran, Iran.

69- Sarcoidosis presenting as a choroidal tumor.

Auther (s) Nazari H. Naseripour M. (Posters) XVIII Ophthalmology Congress of IRAN. 25-27

Nov 2008.

70- Anti angiogenic therapy with intravitreal bevacizumab for aggressive posterior retinopathy of

prematurity (APROP) unresponsive to conventional laser therapy. Nazari H, Parvaresh MM,

Hashemi M, Modarreszadeh M, Naseripour M, Nikeghbali A. (Free papers) XVIII

Ophthalmology Congress of IRAN. 25-27 Nov 2008.

71- Visual function and predictor factors following brachytherapy for circumscribed choroidal

hemangioma. Naseripour M. (Free papers) XVIII Ophthalmology Congress of IRAN. 25-27

Nov 2008.

24

72- Intravitreal use of bevacizumab (avastin) for choroidal neovascularization associated with age

related macular degeneration; a fuul field ERG study. Naseripour M. (Free papers). XVIII


73- Photodynamic therapy in retinal angiomatosis proliferations. Naseripour M. (Free papers).

XVIII Ophthalmology Congress of IRAN. 25-27 Nov 2008.

74- Primary transpupillary thermotherapy for small choridal melanoma. Naseripour M. (Free

papers). XVIII Ophthalmology Congress of IRAN. 25-27 Nov 2008.

75- Ruthenium brachythrapy for retinoblastoma. Naseripour M. (Free papers). XVIII


76- When to continue or to discontinue Avastin in exudative ARMD. Naseripour M

6-8 March 2009, Tehran Razi Convention Center.

77- Pharmacotherapy for retinal capillary hemangioma, vasoproliferative tumors and coat` disease.

Naseripour M.

6-8 March 2009, Tehran Razi Convention Center.

78- When to countinue or to descountinue Avastin in exudative ARMD. 6-8 March.

Naseripour M. 2009, Tehran Razi Convention Center.

79- Pharmacotherapy for retinal capillary hemangioma, vasoproliferative tumors and coat` disease.

Naseripour M. 6-8 March 2009, Tehran Razi Convention Center.

25

80-. Ocular tumor management & it`s complication.12th Iranian Congress of Optometry.

Naseripour M .18-20 August 2009. Tehran Razi Convention Center.

81- Uveal melanoma management : Lessons from cytogenetic profiling .

Naseripour M. 3rd annual meeting of Iranian Retina Society. 22 Apr 2010 . Shiraz

82- Update on retinal disease and glaucoma: Panel discussion.

Naseripour M. 16th annual meeting of TUMS Eye Research center 5-7 May 2010, Tehran

83-. The Role of cataract surgery in macular disease.

Naseripour M . 4th annual meeting of IUMS Eye Research center, 21-23 july 2010 Tehran

84-. Approach to a fundus mass.

Naseripour M, ghasenmi F XXAnnual Congress of the Iran society of Ophthalmology 11-8

1389آذرماه ))

یکروزه -85 سمینار شبکیه سن به وابسته استحاله بیماری در فوندوس نرمال اتوفلورسانیشبکیه ( و پور 19/12/89مورخه) 1زجاجیه ناصری مسعود دکتر

86- Retinoblastoma Survival in Iran.

Naseripour M. SIOP Asia 2010, 3-5 March 2010 Kish Island

87- Surgical approach in Retinoblastoma.

Naseripour M. 6th Congress of the SIOP Asia. March 3-5 2010, Iran-Kish Island

88- Ravindranath Y, Naseripour M, Epelman S, Vossough P.

6th Congress of the SIOP Asia. Mrch 3-5 2010, Iran-Kish Island

89- Workshop: Approach to a fundus mass.

26

Naseripour M. XX Annual Congress of the Iranian Society of ophthalmology Nov.29- Dec.2,

2010

90- Differential diagnosis of an amelanotic fundus mass. XX Annual Congress of the Iranian

Society of ophthalmology Nov.29- Dec.2, 2010.

91- Approach to a fundus mass. Naseripour M. XX Annual Congress of the Iranian Society of

ophthalmology Nov.29- Dec.2, 2010.

92- Updates on managements of AMD. Naseripour M. XX Annual Congress of the Iranian

Society of ophthalmology Nov.29- Dec.2, 2010.

93- Salvage Ru-106 Plaque Radiotherapy after failed primary chemotherapy for advanced

Retinoblastoma . Naseripour M. XX Annual Congress of the Iranian Society of


94-Trends in survival of Retinoblastoma patients in an ocular oncology unit in iran : 1991-2010.

Naseripour M. XX Annual Congress of the Iranian Society of ophthalmology Nov.29- Dec.2,

2010.

95-Controversies in vitreoretinal surgical techniques. (To Peal LIM? / Pros / Cons). Naseripour

M. XX Annual Congress of the Iranian Society of ophthalmology Nov.29- Dec.2, 2010.





27

ماکوال - 98 بیماریهای تشدید باعث کاتاراکت ؟ ARMD , DMEجراحی شود میرمضانی – – – دکتر هاشمی دکتر کارخانه دکتر پور ناصری دکتر

Controversies in ophthalmology 21-23 july 2010

99- EYELID.

Demerci H, Naseripour M.

Biannual Meeting ISOO 2011, 14-17 November.

100- Mystery case.

Naseripour M.

International society of ocular oncology, Biannual Meeting ISOO 2011, 14-17 November.

101- β-Radiation brachytherapy for large choroidal melanoma: Do we need A high dose

to the apex?

Naseripour M, falavarjani KG, Jaberi R, Irani AR, Azma Z.

International society of ocular oncology, Biannual Meeting ISOO 2011, 14-17

November.

102- Multidisciplinary coordinated services: what we need to improve in the management

of RB. Naseripour M, Nazari H, Falavarjani KG, Soudi R, Maleki A, Ansari S.

International society of ocular oncology, Biannual Meeting ISOO 2011, 14-17 November.

103- Central serous chorioretinophaty.

Controversies in ophthalmology 20-22 july 2011.

104- Results of the Comparison of AMD Treatment Trials (CATT Study).

Shahid Beheshti University of Medical Sciences. February 1-3, 2012.

28

105-Moderator of Oncology session in WOC.

Hind Alkatan, Santosh Honavar, Naseripour M, Jacob pe`er, Jerry Shields.

12th MEACO International Congress.16-20 February 2012, Abu Dhabi, United Arab

Emirates.

106- Miscellaneous Tumors / Photodynamic therapy (PDT): is it an effective treatment

modality for retinal and choroidal vascular Tumors?

Naseripour M .12th MEACO International Congress.16-20 February 2012, Abu Dhabi,

United Arab Emirates.

107- Jerry Slields, Naseripour M. Rapid Fire papers: chairpersons.


Emirates.

108 - Rapid Fire papers: Mystery Case. Naseripour M


Emirates.

109- Vitreoretinal considerations in cataract surgery. (Vitreoretinal interface changes after

cataract surgery (OCT Findings)). Naseripour M

کاتاراکت، و قرنیه پیوند فارابی، سالیانه سمینار محمود 1391اردیبهشت 15تا 12هجدهمین ،

مازندران آباد

110- Ocular pathology & tumors 3. Uveal Nevus. APAO/SOE Busan 2012, 13-16 April

2012. Naseripour M. Bexco, Busan, Korea.

111- Invited lecturer by Visual Sciences groups. Chaharshanbe-Soori Injuries Forum.

Naseripour M.

29

ماه 12و 11 فارابی 1390اسفند سمینار

112- Nine Novel RBI Mutation and Genotype/ Phenotype Correlation in Patients with

Retinoblastoma Referred to Rassoul Akram Hospital. Naseripour M.

ماه 12و 11 فارابی 1390اسفند سمینار113- Naseripour M. Update in Retinoblastoma

ماه 12و 11 -1391خرداد رشت کنار زیبا

115- MasoodNaseripourand ArunD.Singh ,Retinoblstoma:Enucleation Chapter in”

Pocket Guild to Ocular Oncology and Pathology”by Hans E.Grossniklaus.Springer

Heidelberg New York Dordrecht London ISBN 978-3-642-28911-8,2012.

116- Naseripour M. How far do you continue the treatment in exudative ARMD?

Controversies in ophthalology .Eye Research Center,Rassoul Akram Hospital,Tehran

Unversity of Medical Sciences. 11-13 jul 2012.

117- Symposium: Retina Disease (Part1), (Results of the comparison of AMD Treatment

Trials (CATT Study)): Naseripour M . Advances and innovations in ophthalmology. 7th

Annual Meeting of the Ophthalmic Research Center. Shahid beheshti University of

Medical Sciences. February 1-3, 2012.

118- Vitreoretinal considerations in cataract surgery. (Vitreoretinal interface changes after

cataract surgery (OCT Findings)). Masood Naseripour. سالیانه سمینار هجدهمین

. مازندران , آباد محمود کاتاراکت و قرنیه پیوند 1391اردیبهشت 15تا 12 فارابی،

119- Naseripour Masood,Live surgery Performed in XXII Annual Congress Of The

Iranian Society Of Ophthalmology ,30 oct2012.

30

120- Naseripour Masood,Free Papers:Posterior Segment, Moderated in XXII Annual

Congress Of The Iranian Society Of Ophthalmology ,31oct2012.

121- Naseripour Masood,Temporary Keratoprosthesis:TPK,K-pro..Video Presented in

posterior Segment Trauma Workshop in XXII Annual Congress Of The Iranian Society Of

Ophthalmology ,1nov2012

122- Naseripour Masood,Genotype – Phenotype Correlation in Iranian Patients with

Retinoblastoma, Oral Presentation in XXII Annual Congress Of The Iranian Society Of

Ophthalmology ,1nov2012.

123- Naseripour Masood,The Trend in the Survival of the Patient with Retinoblastoma,

Poster Presentation in XXII Annual Congress Of The Iranian Society Of

Ophthalmology ,1nov2012.

124- Nasseripour Masoud, The Chair of Free Paper, IRAVO Congress, 7march 2013

125- Nasseripour Masoud,Genotype-Phenotype Correlation in Iranian Patients with

Retinoblastoma,Oral Presentation in IRAVO Congress, 8march 2013

126- . . در ارائه فوندوس پیگمانته ضایعات به رویکرد پور ناصری مسعود فوق دکتر برنامه

. : رتین و ویتره بیماریهای به رویکرد رتین گروه و تخصصی فارابی سالیانه سینار نوزدهمین

،هتل ایران،تهران پزشکی چشم انجمن رتین و ویتر تخصصی فوق گروه گردهمایی ششمین

، فارابی .1392اردیبهشت 5المپیک سالیانه سینار نوزدهمین

127- . . کاتاراکت جراحی از پس اندوفتالمیت پور ناصری مسعود :ارائه دکتر سمپوزیوم در

. گردهمایی ششمین و فارابی سالیانه سینار نوزدهمین کاتاراکت جراحی از پس اندوفتالمیت ، المپیک ،هتل ایران،تهران پزشکی چشم انجمن رتین و ویتر تخصصی فوق 6گروه

فارابی .1392اردیبهشت سالیانه سینار نوزدهمین

31

Teaching Experience

Topic 1: Ophthalmology

Topic 2: Medical Education

33

Education:iums.ac.ir/uploads/cvdrnaserypor.docx · Web viewCurriculum Vitae PERSONAL INFORMATION:...

Documents

Transcript of Education:iums.ac.ir/uploads/cvdrnaserypor.docx · Web viewCurriculum Vitae PERSONAL INFORMATION:...